CSCJC3456

· Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSCJC3456, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CSCJC3456 in Patients With Advanced Malignant Tumors [Phase 1]